Novartis
Remains on the Top for Meeting Managed Care Executives’ Overall Needs,
Cognet-X Announces
FEASTERVILLE---(May 13,
2003)---For the second consecutive ranking period, influential managed care
pharmacy directors have rated Novartis Pharmaceuticals Corp. as the
pharmaceutical company that best meets their overall needs, Cognet-X, Inc.
reported today.
Novartis previously ranked
first in the Overall Needs assessment category in the third-quarter 2002
ranking period of the twice-yearly Corporate Assessment Total Rankings
component of Cognet-X’s PAR-Rx (Promotional Assessment Research) Report™.
Novartis received a total of
362 points through Cognet-X’s proprietary Scale of Influence model,
generating 11% more points than its nearest competitor, Aventis Pharma AG.
Aventis rose from fourth place in the 3Q 2002 rankings to second place.
“Excellent clinical
pharmacy support resources; consistent, knowledgeable account management
support; great customer-relationship building services,” commented one
PAR-Rx panelist about selecting Novartis as the best company. “Good
portfolio of products; good pipeline; regional account manager is responsive
to [our] needs,” noted another pharmacy director.
PAR~Rx panelists also ranked
Novartis first in the Knowledgeable Account Manager/Personnel, Value-added
Services and Advisory Board/Seminars/CE Programs categories in this assessment
period. The Advisory Board category made its debut as a PAR-Rx Report
assessment category in the first quarter of this year. Cognet-X added this
category in response to client input.
Wyeth, formerly known as
American Home Products, climbed to third place in the most recent assessment
cycle, up from seventh place in 3Q 2002.
Aventis and Wyeth were among
four top-10 corporations that received higher rankings in the 1Q 2003 cycle,
the others being AstraZeneca PLC (from ninth to sixth) and Pharmacia Corp.
(previously ranked 14th).
PAR-Rx
panelists also ranked Merck & Co. Inc. and GlaxoSmithKline in the top five
corporations for best meeting their Overall Needs. Rounding out the top 10:
Pharmacia Corp. (pre-merger with Pfizer Inc.), Forest Laboratories Inc., Novo
Nordisk Pharmaceuticals and TAP Pharmaceuticals Inc.
About the PAR-Rx Report
Cognet-X’s PAR-Rx Report is a year-round service that
provides the pharmaceutical industry with real-time, Internet-based
competitive intelligence on pharmaceutical company promotion to influential
managed care pharmacy directors.
The Report offers Cognet-X clients the ability to
evaluate and analyze variable differences that are critically important to
their decision-making process. The Report collects comprehensive data that can
be segmented and analyzed to provide clients with “21st-Century
solutions to their 21st-Century challenges.”
About Cognet-X
Cognet-X offers the pharmaceutical industry market
research, consulting and software development that help companies build and
refine their relationships with numerous customer bases, including the managed
care community. Based in Bucks County, Pennsylvania, Cognet-X is privately
held and employee-owned.
For more information on the PAR-Rx Report or other
valuable Cognet-X products, please contact Robert E. Houghton (extension 101)
or James A. Barone (extension 102) at (215) 396-8300 or via e-mail at
robh@cognetx.com
or
jimb@cognetx.com.
